Search

everythinglearnresearchcommunity

for

Search:↓

A chemical called 5-Bromo-2′-deoxyuridine caused rapid hair loss in mice by killing certain skin cells through a specific cell death pathway.

Skin irritants can promote hair growth by affecting specific skin proteins.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Skin cells can naturally limit the growth of cancerous changes by balancing cell renewal and differentiation.

Janus kinase inhibitors help hair regrowth in kids with alopecia areata but need more safety research.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

Increased ODC activity leads to skin tumors by recruiting stem cells, not by toxic byproducts.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

L-cystine, D-pantothenat, and miliacin together significantly boost keratinocyte growth and metabolism.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Inactivating both p53 and Rb genes in mice speeds up aggressive skin cancer development.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

Mutant CDP/Cux protein causes hair defects and reduced male fertility in mice.

Skin reactions from cancer treatments might predict how well the treatments work.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

A peptide in shampoo can promote hair growth and improve hair condition.

Dermatologists are hesitant to prescribe Janus kinase inhibitors for alopecia areata due to safety concerns and lack of knowledge.

Estradiol stops hair growth in mice, but an antagonist can reverse this effect.

PRIDE syndrome includes skin and hair issues from cancer treatment with EGFR inhibitors.

Cyclosporin A and FK506 can start new hair growth in mice, but ascomycin and rapamycin cannot.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Upadacitinib effectively treated severe hair loss in a child.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.